Komori
T

TENTIAL Inc.

325AMaterials and ChemicalsMicro cap
1,230JPY-37.2%
★ Watch (sign-up required)
Price history
¥1,230Latest+34.1%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview

A summary lands here once the filings have been read.

Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
Loading
Documents
See all timely disclosuresSee all statutory filings
News
See all news
Key numbersShowing 8 of 19
PER
15.18How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.
PBR
4.79How many times the company's net assets? Around 1x is generally considered a benchmark.
ROE
31.5%Earning power. A figure above 10% is generally considered good.
Dividend yield
0.0%The annual dividend as a percentage of the share price.
Market capitalization
¥28bnShare price × number of shares. The value of the entire company.
Equity ratio
53.7%The proportion of assets funded by money that does not have to be repaid.
Operating margin
11.0%The percentage of revenue remaining from the company’s core business.
Revenue growth (3 years)
58.1%The average annual growth in sales over the past three years.
What to watch next
Additional openings of directly operated stores, expanding the store network, and stabilizing sales, inventory and gross profit as the number of stores increases
From the next fiscal period through each quarterly earnings announcementImpact MediumLikelihood Medium
The launch and performance by SKU of new BAKUNE/recovery-wear products, such as the BAKUNE Premium Warm Duvet
From launch or the start of sales through the next several quartersImpact MediumLikelihood Medium
Results from in-house development of the company’s data platform and improvements to e-commerce UI/UX, including conversion rate, average order value, repeat-purchase rate and churn rate
Continuously from the next fiscal period onwardImpact MediumLikelihood Medium
The effectiveness of supply stability and cost management, including foreign-exchange hedging, related to contract manufacturing by 豊島株式会社 and the concentration of purchases
During each period of foreign-exchange volatilityImpact HighLikelihood Medium
Whether regulatory operations related to medical devices, including notifications, licenses and the proper management of advertising and labeling, can continue as expected
Ongoing monitoring, at each renewal and operational stageImpact HighLikelihood Low
What to watch next
Loading
Who owns itTop holders total 59.5%
Listed holders 59.5%Everyone else 40.5%
Nakanishi Yutaro (中西 裕太郎)26.74%
株式会社Anchor7.79%
株式会社日本カストディ銀行 (Trust Account)4.78%
Nomura Trust and Banking Co., Ltd. (Investment Trust Account)4.04%
ベル投資事業有限責任組合13.67%
豊島株式会社3.31%
Morgan Stanley MUFG Securities Co., Ltd.3.01%
PARAMOUNT BED-SBI Healthcare Fund1号投資事業有限責任組合2.09%
2 other listed holders4.03%
Who owns it
HolderOwnership (%)
Nakanishi Yutaro (中西 裕太郎)26.74
株式会社Anchor7.79
株式会社日本カストディ銀行 (Trust Account)4.78
Nomura Trust and Banking Co., Ltd. (Investment Trust Account)4.04
ベル投資事業有限責任組合13.67
豊島株式会社3.31
Morgan Stanley MUFG Securities Co., Ltd.3.01
PARAMOUNT BED-SBI Healthcare Fund1号投資事業有限責任組合2.09
2 other listed holders4.03
This company's documents
Filings
Timely disclosures
Threads